Compagnie Lombard Odier SCmA’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,000	Closed	-$3K	–	1035
2016 Q1	$3K	Hold	2,000	–	–	﹤0.01%	943
2015 Q4	$3K	Hold	2,000	–	–	﹤0.01%	914
2015 Q3	$3K	Hold	2,000	–	–	﹤0.01%	795
2015 Q2	$3K	Hold	2,000	–	–	﹤0.01%	810
2015 Q1	$3K	Hold	2,000	–	–	﹤0.01%	933
2014 Q4	$3K	Hold	2,000	–	–	﹤0.01%	752
2014 Q3	$4K	Hold	2,000	–	–	﹤0.01%	848
2014 Q2	$6K	Hold	2,000	–	–	﹤0.01%	858
2014 Q1	$5K	Buy	+2,000	New	+$5K	﹤0.01%	847

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Compagnie Lombard Odier SCmA's RXII Position: Q2 2016 in Review

Compagnie Lombard Odier SCmA sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2016, closing a stake of 2,000 shares — an estimated $3K sold.

Compagnie Lombard Odier SCmA first reported a position in RXII in Q1 2014 and held it in 9 quarters. The position peaked at $6K in Q2 2014. 90 funds tracked by Wall St. Rank hold RXII as of Q2 2016.

Compagnie Lombard Odier SCmA reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2016 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 2,000 GALENA BIOPHARMA INC COM shares in Q2 2016, an estimated $3K.
Compagnie Lombard Odier SCmA first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 9 quarters.
Compagnie Lombard Odier SCmA's GALENA BIOPHARMA INC COM position peaked at $6K in Q2 2014.
90 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2016, filed 15 Aug 2016.